If you read content stating that GHK-Cu injectable is illegal in the United States, including our own earlier version of this post, that information is outdated as of April 2026
Its bacteriostatic properties make it suitable for repeated use from a single vial under proper sterile conditions
Al-Oqail MM, Al-Sheddi ES, Farshori NN, Al-Massarani SM, Al-Turki EA, Ahmad J, Al-Khedhairy AA, Siddiqui MA
This pulsatility is physiologically importantGH receptor sensitivity, downstream signaling responses, and metabolic effects all depend on intermittent rather than continuous stimulation
The Three Pillars of Glutathiones Power First, as an antioxidant powerhouse, glutathione deactivates free radicalsthose marauding molecules from pollution or ultraviolet light that damage DNA and speed aging
Today Ely Lilly (LLY) announced the positive results on a phase 2 diabetes drug of theirs ( LY3298176 ) via a publication in The Lancet, a presentation at the annual meeting of the European Association for the Study of Diabetes (EASD) and the press release below: Lilly's Investigational Dual GIP and GLP-1 Receptor Agonist Shows Significant Reduction in HbA1c and Body Weight in People With Type 2 Diabetes The press release created a few headlines: Bloomberg: Diabetes Drug's Results Push Lilly to Look at Obesity Too Reuters: Lilly's diabetes drug data impresses, hurts rival Novo's shares The share price of Eli Lilly went up by 4% in an otherwise sour market and that of Danish rival Novo Nordisk (NOVO-B.CO) plummeted some 7-8%